These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 7969039

  • 1. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells.
    Ritke MK, Rusnak JM, Lazo JS, Allan WP, Dive C, Heer S, Yalowich JC.
    Mol Pharmacol; 1994 Oct; 46(4):605-11. PubMed ID: 7969039
    [Abstract] [Full Text] [Related]

  • 2. Differential oncogene expression and susceptibility to apoptosis in the human leukemia HL60 cell lines: implications for etoposide resistance.
    Eliot HE, Borner MM, Sinha BK.
    Anticancer Res; 1995 Oct; 15(3):729-33. PubMed ID: 7645949
    [Abstract] [Full Text] [Related]

  • 3. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells.
    Bullock G, Ray S, Reed J, Miyashita T, Maria Ibrado A, Huang Y, Bhalla K.
    Clin Cancer Res; 1995 May; 1(5):559-64. PubMed ID: 9816016
    [Abstract] [Full Text] [Related]

  • 4. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
    Eymin B, Dubrez L, Allouche M, Solary E.
    Cancer Res; 1997 Feb 15; 57(4):686-95. PubMed ID: 9044846
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of etoposide (VP-16)-induced DNA recombination and mutant frequency by Bcl-2 protein overexpression.
    Hashimoto H, Chatterjee S, Berger NA.
    Cancer Res; 1995 Sep 15; 55(18):4029-35. PubMed ID: 7664276
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K.
    Cancer Res; 1996 Oct 15; 56(20):4743-8. PubMed ID: 8840993
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.
    Ritke MK, Allan WP, Fattman C, Gunduz NN, Yalowich JC.
    Mol Pharmacol; 1994 Jul 15; 46(1):58-66. PubMed ID: 8058057
    [Abstract] [Full Text] [Related]

  • 10. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death.
    Catchpoole DR, Stewart BW.
    Cancer Res; 1993 Sep 15; 53(18):4287-96. PubMed ID: 8364925
    [Abstract] [Full Text] [Related]

  • 11. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F, Bae I, Fornace AJ, Pommier Y.
    Oncol Res; 1996 Sep 15; 8(7-8):317-23. PubMed ID: 8938795
    [Abstract] [Full Text] [Related]

  • 12. Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.
    Rubin E, Kharbanda S, Gunji H, Kufe D.
    Mol Pharmacol; 1991 Jun 15; 39(6):697-701. PubMed ID: 1904980
    [Abstract] [Full Text] [Related]

  • 13. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
    Zwelling LA, Chan D, Hinds M, Mayes J, Silberman LE, Blick M.
    Cancer Res; 1988 Dec 01; 48(23):6625-33. PubMed ID: 2846155
    [Abstract] [Full Text] [Related]

  • 14. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression.
    Bertrand R, Sarang M, Jenkin J, Kerrigan D, Pommier Y.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6280-5. PubMed ID: 1933888
    [Abstract] [Full Text] [Related]

  • 15. [Mechanisms of drug resistance of two cell lines of human chronic promyelocytic leukemia K562, resistant to DNA topoisomerase II inhibitors adriamycin and etoposide].
    Meliksetian MB, Berezkina EV, Pavlenko MA, Grinchuk TM.
    Tsitologiia; 1999 Dec 01; 41(7):615-21. PubMed ID: 10496023
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
    Blood A, Edwards CJ, Ishii HH, Pat BK, Bryson G, Sculley TB, Gobe GC.
    Arch Virol; 2004 Feb 01; 149(2):289-302. PubMed ID: 14745596
    [Abstract] [Full Text] [Related]

  • 17. [New insight into the mechanism of p53 inducing leukemia cell apoptosis].
    Chen YZ, Wu Y, Liang M, Li NN, Zhang ZX, Lu LH.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Dec 01; 24(12):640-3. PubMed ID: 14761612
    [Abstract] [Full Text] [Related]

  • 18. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G, Chang BS, Kim CN, Perkins C, Thompson CB, Bhalla KN.
    Cancer Res; 1998 Aug 01; 58(15):3202-8. PubMed ID: 9699642
    [Abstract] [Full Text] [Related]

  • 19. bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair.
    Kamesaki S, Kamesaki H, Jorgensen TJ, Tanizawa A, Pommier Y, Cossman J.
    Cancer Res; 1993 Sep 15; 53(18):4251-6. PubMed ID: 8395979
    [Abstract] [Full Text] [Related]

  • 20. Herbimycin A accelerates the induction of apoptosis following etoposide treatment or gamma-irradiation of bcr/abl-positive leukaemia cells.
    Riordan FA, Bravery CA, Mengubas K, Ray N, Borthwick NJ, Akbar AN, Hart SM, Hoffbrand AV, Mehta AB, Wickremasinghe RG.
    Oncogene; 1998 Mar 26; 16(12):1533-42. PubMed ID: 9569020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.